BECKY WELLS: Open Payments
NPI 1780617811 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 15 payments from 12 companies in 2025. Trend: 2023 $191 · 2024 $572 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $104 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| PFIZER INC. | 2 | $41 |
| ABBVIE INC. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
Products named: Yescarta, TRELEGY ELLIPTA, QULIPTA, LEQVIO, FREESTYLE LIBRE 3, FARXIGA, ELIQUIS, SPRAVATO.
Industry payments across ID — which companies pay providers there.
